|
|
 |
| Stemgent® mRNA Reprogramming Kit |
|
| Description |
The Stemgent mRNA Reprogramming Kit contains three essential components for productive non-integrative reprogramming: the Stemgent mRNA Reprogramming Factors: OSKM, the Stemgent Pluriton™ Reprogramming Medium and B18R recombinant protein, carrier-free. Stemgent functionally validates all three components together. The in vitro transcribed mRNA’s encoding Oct4, Klf4, Sox2, c-Myc, Lin-28 factors and the nuclear GFP (nGFP) control, fluorescent reporter incorporate both pseudouridine and 5-methylcytidine-modified nucleotides, and when used in combination with the B18R recombinant protein minimize the cellular interferon response to single stranded RNA.1,2 Repeated transfection of mRNA encoding Oct4, Klf4, Sox2, c-Myc and Lin-28 has been shown to reprogram human fibroblasts.3 nGFP mRNA is included for use as a positive control for RNA transfection during the cellular reprogramming process. In addition, the Pluriton Reprogramming Medium is a xeno-free medium included in the kit that was designed to support the robust and reproducible mRNA reprogramming of human fibroblasts.
Learn more about the Stemgent mRNA Reprogramming System. |
| Disclaimer |
| This Stemgent® Product is exclusively distributed by Miltenyi Biotec outside the USA and Israel. |
| Specifications and technical documents |
| Specification SheetsMaterial Safety Data SheetsBrochuresManualsOther Support Documents
|
| | |
|
 |
| Favorites / Prices |
Request prices or add products to your favorite list.
|
| Details |
|
| Products |
| Stemgent mRNA Reprogramming Kit |
- 1 kit - Stemgent #00-0071 130-097-191
|
|
| References |
| 1. Angel, M. and Yanik, M.F. (2010) PLoS One 5:e11756. |
| 2. Warren, L. et al. (2010) Cell Stem Cell. 7: 618-630. |
| 3. Yakubov, E. et al. (2010) Biochem Biophys Res Commun. 394: 189-193. |
|
| MACS Stem Cell newsletter |
|
Stay current with important developments in stem cell research by subscribing to
Stem Cell Updates.
|
|
© 1999 - 2012 Miltenyi Biotec ¦ Terms & conditions ¦ Legal notes
|